Your browser doesn't support javascript.
loading
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
Casulo, Carla; Larson, Melissa C; Lunde, Julianne J; Habermann, Thomas M; Lossos, Izidore S; Wang, Yucai; Nastoupil, Loretta J; Strouse, Christopher; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Kahl, Brad S; Burack, W Richard; Koff, Jean L; Mun, Yong; Masaquel, Anthony; Wu, Mei; Wei, Michael C; Shewade, Ashwini; Li, Jia; Cerhan, James; Flowers, Christopher R; Link, Brian K; Maurer, Matthew J.
Afiliación
  • Casulo C; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA. Electronic address: carla_casulo@urmc.rochester.edu.
  • Larson MC; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Lunde JJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Habermann TM; Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Lossos IS; Department of Medicine, Comprehensive Sylvester Cancer Center, University of Miami, Miami, FL, USA.
  • Wang Y; Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Nastoupil LJ; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Strouse C; Department of Medicine, University of Iowa, Iowa City, IA, USA.
  • Chihara D; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Martin P; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Kahl BS; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Burack WR; Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY, USA.
  • Koff JL; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Mun Y; Genentech, South San Francisco, CA, USA.
  • Masaquel A; Genentech, South San Francisco, CA, USA.
  • Wu M; Genentech, South San Francisco, CA, USA.
  • Wei MC; Genentech, South San Francisco, CA, USA.
  • Shewade A; Genentech, South San Francisco, CA, USA.
  • Li J; Genentech, South San Francisco, CA, USA.
  • Cerhan J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Flowers CR; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Link BK; Department of Medicine, University of Iowa, Iowa City, IA, USA.
  • Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Lancet Haematol ; 9(4): e289-e300, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35358443
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Folicular Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans Idioma: En Revista: Lancet Haematol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Folicular Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans Idioma: En Revista: Lancet Haematol Año: 2022 Tipo del documento: Article